Riskpilot← Back to searchSign inGet full accessmalSkin AB
ABActiveOrg 5593661712Föreningsgatan 83 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-438% vs 2023
Equity ratio
83.4%
Financial strength
Net profit 2024
SEK -287K
-1373% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -105K | -438% |
| Net profit | SEK -287K | -1373% |
| Total assets | SEK 151K | -66% |
| Equity | SEK 126K | +23% |
| Employees | 0 | — |
Legal name
malSkin AB
Org number
5593661712
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 februari 2022
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk forskning och läkemedel och därmed förenlig verksamhet.
Address
Föreningsgatan 83 A
Email
hakan.hallstrom@gulliksson.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −143 | −19 | −105 |
| Depreciation & amort. | — | — | −182 |
| EBIT | −143 | −19 | −287 |
| Net financials | — | — | 0 |
| Profit before tax | −143 | −19 | −287 |
| Tax | — | — | — |
| Net profit | −143 | −19 | −287 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 225 | 438 | 151 |
| Equity | 56 | 102 | 126 |
| Long-term debt | — | — | — |
| Short-term debt | 169 | 336 | 25 |
| Total debt | 169 | 336 | 25 |
EBITDA margin
-10482500.0%
This company
15.8%
Market median
-66345037% vs market
20222024
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
20222024
Return on equity
-228.4%
This company
18.4%
Market median
-1341% vs market
20222024
Net profit margin
-28690200.0%
This company
8.1%
Market median
-354200100% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HJ Chief Executive Officer | Chief Executive Officer | 2022 |
CA | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of malSkin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Johan Malm | Chief Executive Officer | 0 companies |
| Curt Arne Jesper Ahlkvist | Audit | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| György Marko-Varga | Board of Directors | 0 companies |
| Ture Jonas Christer Gulliksson | Chairman | 0 companies |
| Peter Horvath | Board of Directors | 0 companies |
| Hans Erik Roger Appelqvist | Board of Directors | 0 companies |
| István Balázs Nemeth | Board of Directors | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |